MX368985B - Compuestos novedosos de imidazobenzotiazol fusionado. - Google Patents
Compuestos novedosos de imidazobenzotiazol fusionado.Info
- Publication number
- MX368985B MX368985B MX2016012535A MX2016012535A MX368985B MX 368985 B MX368985 B MX 368985B MX 2016012535 A MX2016012535 A MX 2016012535A MX 2016012535 A MX2016012535 A MX 2016012535A MX 368985 B MX368985 B MX 368985B
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- novel fused
- pharmaceutically acceptable
- fused imidazobenzothiazole
- present
- Prior art date
Links
- HWAXRLFNEXLBSN-UHFFFAOYSA-N 2h-imidazo[4,5-g][1,3]benzothiazole Chemical class C1=CC2=NCSC2=C2N=CN=C21 HWAXRLFNEXLBSN-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invención se refiere a derivados novedosos de imidazobenzoizol fusionados sus sales farmacéuticamente aceptables y sus isómeros, estereoisómeros, atropisómeros, confórmeros, tautómeros, hidratos, solvatos y N-óxido. La presente invención también incluye composiciones farmacéuticamente aceptables de dichos compuestos y proceso para la preparación de nuevos compuestos. La invención además se refiere al uso de los compuestos mencionados anteriormente para la preparación de medicamento para uso como farmacéuticos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1089MU2014 | 2014-03-27 | ||
| PCT/IB2015/052124 WO2015145336A1 (en) | 2014-03-27 | 2015-03-24 | Novel fused imidazobenzothiazole compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016012535A MX2016012535A (es) | 2017-05-04 |
| MX368985B true MX368985B (es) | 2019-10-23 |
Family
ID=54194050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016012535A MX368985B (es) | 2014-03-27 | 2015-03-24 | Compuestos novedosos de imidazobenzotiazol fusionado. |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US9908898B2 (es) |
| EP (1) | EP3122755B1 (es) |
| JP (1) | JP6480949B2 (es) |
| KR (1) | KR102339610B1 (es) |
| CN (1) | CN106414458B (es) |
| AR (1) | AR099867A1 (es) |
| AU (1) | AU2015237840B2 (es) |
| CA (1) | CA2943098C (es) |
| CY (1) | CY1121147T1 (es) |
| DK (1) | DK3122755T3 (es) |
| EA (1) | EA029745B9 (es) |
| ES (1) | ES2707099T3 (es) |
| HR (1) | HRP20190121T1 (es) |
| HU (1) | HUE042493T2 (es) |
| IL (1) | IL247955B (es) |
| LT (1) | LT3122755T (es) |
| MX (1) | MX368985B (es) |
| MY (1) | MY193041A (es) |
| PH (1) | PH12016501903B1 (es) |
| PL (1) | PL3122755T3 (es) |
| PT (1) | PT3122755T (es) |
| RS (1) | RS58324B1 (es) |
| SG (1) | SG11201607793RA (es) |
| SI (1) | SI3122755T1 (es) |
| SM (1) | SMT201900036T1 (es) |
| TR (1) | TR201900735T4 (es) |
| TW (1) | TWI648282B (es) |
| UA (1) | UA121469C2 (es) |
| WO (1) | WO2015145336A1 (es) |
| ZA (1) | ZA201606598B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX379228B (es) | 2013-03-15 | 2025-03-10 | Global Blood Therapeutics Inc | Compuestos y usos de estos para la modulación de la hemoglobina. |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| TWI648282B (zh) * | 2014-03-27 | 2019-01-21 | 印度商托仁特生技有限公司 | 新熔合咪唑苯并噻唑化合物 |
| DE102016209204A1 (de) | 2016-05-27 | 2017-11-30 | Robert Bosch Gmbh | Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug |
| KR102630959B1 (ko) * | 2016-10-31 | 2024-01-29 | 엘지디스플레이 주식회사 | 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치 |
| CN106727538A (zh) * | 2017-02-20 | 2017-05-31 | 潘连香 | 一种治疗2型糖尿病的药物组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724566D0 (en) * | 1987-10-20 | 1987-11-25 | Roussel Lab Ltd | Chemical compounds |
| GB8908845D0 (en) * | 1989-04-19 | 1989-06-07 | Roussel Lab Ltd | Chemical compounds |
| AU2381995A (en) | 1994-04-29 | 1995-11-29 | Pharmacia & Upjohn Company | Methanol derivatives for treatment of retroviral infections especially hiv infections |
| AU2001294515A1 (en) | 2000-08-11 | 2002-02-25 | The Regents Of The University Of California | Use of stat-6 inhibitors as therapeutic agents |
| US7601846B2 (en) * | 2001-06-26 | 2009-10-13 | The Regents Of The University Of California | Compounds having activity as inhibitors of apoptosis |
| BR0316506A (pt) * | 2002-11-25 | 2005-10-04 | Pharmacia Corp | Midas e ácidos heteroarilsulfonilmetil hidroxâmicos e sua aplicação como inibidores da protease |
| GB0320244D0 (en) * | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
| US20090012079A1 (en) * | 2006-02-09 | 2009-01-08 | Russell Andrew Lewthwaite | Triazolopyridine Compounds |
| TWI648282B (zh) * | 2014-03-27 | 2019-01-21 | 印度商托仁特生技有限公司 | 新熔合咪唑苯并噻唑化合物 |
-
2015
- 2015-03-16 TW TW104108329A patent/TWI648282B/zh not_active IP Right Cessation
- 2015-03-24 JP JP2016559356A patent/JP6480949B2/ja not_active Expired - Fee Related
- 2015-03-24 TR TR2019/00735T patent/TR201900735T4/tr unknown
- 2015-03-24 PL PL15717242T patent/PL3122755T3/pl unknown
- 2015-03-24 CA CA2943098A patent/CA2943098C/en active Active
- 2015-03-24 ES ES15717242T patent/ES2707099T3/es active Active
- 2015-03-24 HR HRP20190121TT patent/HRP20190121T1/hr unknown
- 2015-03-24 RS RS20190084A patent/RS58324B1/sr unknown
- 2015-03-24 US US15/128,886 patent/US9908898B2/en active Active
- 2015-03-24 CN CN201580024068.6A patent/CN106414458B/zh not_active Expired - Fee Related
- 2015-03-24 UA UAA201610628A patent/UA121469C2/uk unknown
- 2015-03-24 KR KR1020167029134A patent/KR102339610B1/ko not_active Expired - Fee Related
- 2015-03-24 SI SI201530555T patent/SI3122755T1/sl unknown
- 2015-03-24 HU HUE15717242A patent/HUE042493T2/hu unknown
- 2015-03-24 EA EA201691920A patent/EA029745B9/ru not_active IP Right Cessation
- 2015-03-24 SM SM20190036T patent/SMT201900036T1/it unknown
- 2015-03-24 PT PT15717242T patent/PT3122755T/pt unknown
- 2015-03-24 EP EP15717242.0A patent/EP3122755B1/en active Active
- 2015-03-24 WO PCT/IB2015/052124 patent/WO2015145336A1/en not_active Ceased
- 2015-03-24 LT LTEP15717242.0T patent/LT3122755T/lt unknown
- 2015-03-24 MX MX2016012535A patent/MX368985B/es active IP Right Grant
- 2015-03-24 AU AU2015237840A patent/AU2015237840B2/en not_active Ceased
- 2015-03-24 SG SG11201607793RA patent/SG11201607793RA/en unknown
- 2015-03-24 MY MYPI2016703533A patent/MY193041A/en unknown
- 2015-03-24 DK DK15717242.0T patent/DK3122755T3/en active
- 2015-03-27 AR ARP150100915A patent/AR099867A1/es not_active Application Discontinuation
-
2016
- 2016-09-21 IL IL247955A patent/IL247955B/en active IP Right Grant
- 2016-09-23 ZA ZA2016/06598A patent/ZA201606598B/en unknown
- 2016-09-27 PH PH12016501903A patent/PH12016501903B1/en unknown
-
2018
- 2018-01-03 US US15/861,399 patent/US10227361B2/en active Active
-
2019
- 2019-01-21 CY CY20191100076T patent/CY1121147T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
| PH12016501440A1 (en) | Novel heterocyclic compounds | |
| PH12017500281A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| MX2017010477A (es) | Compuestos triciclicos y usos de los mismos en medicina. | |
| PH12017500166A1 (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| TW201613567A (en) | Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament | |
| EA033281B1 (ru) | Азабензимидазолы и их применение в качестве модуляторов рецептора ampa | |
| PH12016501903A1 (en) | Novel fused imidazobenzothiazole compounds | |
| MY175854A (en) | Novel quinolone derivatives | |
| TW201613864A (en) | Novel compounds | |
| GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| ZA201903291B (en) | Fused bicylic pyridine compounds and their use as ampa receptor modulators | |
| MX382128B (es) | Derivados de piridin-2-ona fusionados triciclicos, y su uso como inhibidores de brd4. | |
| PH12017501830A1 (en) | Novel pyridinium compounds | |
| MX2016009621A (es) | Derivados de fur0-3-carboxamida y metodos de uso. | |
| MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
| MY157629A (en) | Fused thiazolo and oxazolo pyrimidinones | |
| IN2013MU00665A (es) | ||
| PH12017500323B1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| IN2014KO00191A (es) | ||
| IN2013MU03838A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |